Abstract

This prospective multicentric study aiming to determine the incidence of complications (malignant transformation, torsion or rupture) during conservative management of adnexal masses was performed in two Portuguese tertiary referral hospitals. It included ≥18-year-old, non-pregnant patients with asymptomatic adnexal masses (associated IOTA ADNEX risk of malignancy < 10%) sonographically diagnosed between January 2016 and December 2020. Conservative patient management consisted of serial clinical and ultrasound assessment up to 60 months of follow-up, spontaneous resolution of the formation or surgical excision (median follow-up: 17.8; range 9–48 months). From the 573 masses monitored (328 premenopausal and 245 postmenopausal adnexal masses), no complications were observed in 99.5%. The annual lesion growth rates and increases in morphological complexity were similar in the premenopausal and postmenopausal patients. Spontaneous resolution, evidenced in 16.4% of the patients, was more common in the premenopausal group (p < 0.05). Surgical intervention was performed in 18.4% of the cases; one borderline and one invasive FIGO IA stage cancer were diagnosed. There was an isolated case of ovary torsion (0.17%). These data support conservative management as a safe option for sonographically benign, stable and asymptomatic adnexal masses before and after menopause and highlight the need for expedite treatment of symptomatic or increased-morphological-complexity lesions.

Highlights

  • Most adnexal masses are incidentally diagnosed by pelvic imaging and the vast majority is benign [1,2]

  • During the study inclusion period (60 months), 685 patients were diagnosed with 797 adnexal masses that were selected according to previous detailed inclusion criteria (Figure 1)

  • Adnexal formations with the ADNEX risk of malignancy

Read more

Summary

Introduction

Most adnexal masses are incidentally diagnosed by pelvic imaging and the vast majority is benign [1,2]. Due to the concern that detected adnexal masses can be malignant or may suffer malignant transformation [1,2,3], nearly 200,000 women undergo pelvic surgery each year in the United States alone, of which

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call